Klampenborg, Denmark

Klaus Edvardsen

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Lund, SE (2008 - 2012)
  • Klampenborg, DK (2005 - 2017)

Company Filing History:


Years Active: 2005-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Inventive Journey of Klaus Edvardsen: Pioneering Cancer Treatments

Introduction: Klaus Edvardsen, a prolific inventor hailing from Klampenborg, Denmark, has made significant strides in the field of oncology with a remarkable portfolio of 10 patents. His innovative approaches to cancer treatment have brought hope to many patients worldwide.

Latest Patents:

1. Methods and antibodies for treating cancer: Klaus Edvardsen's groundbreaking invention focuses on novel treatment methods for tumors. By administering a bispecific antibody or a combination of non-cross-blocking antibodies that target the same antigen, he has paved the way for inducing complement-mediated cell killing in tumor treatment.

2. Method of treating rash in patients undergoing anti-EGFR therapy: In another notable patent, Edvardsen addresses the dermatological side-effects of anti-EGFR treatment. His method involves administering a combination of an anti-EGFR agent and an anti-neutrophil-chemoattractant agent to mitigate unwanted side effects, offering a more comprehensive approach to patient care.

Career Highlights: Edvardsen has lent his expertise to esteemed organizations such as Oxigene, Inc. and Baylor University, where his innovative thinking and dedication to advancing cancer therapeutics have left an indelible mark. His tenure at these institutions has been characterized by a relentless pursuit of cutting-edge solutions for medical challenges.

Collaborations: Throughout his career, Edvardsen has collaborated with leading experts in the field, including David J Chaplin and Kevin G Pinney. These collaborations have not only fostered innovation but have also enriched the scientific community with valuable insights and discoveries.

Conclusion: Klaus Edvardsen's passion for improving cancer treatment methodologies has propelled him to the forefront of medical innovation. His patents stand as a testament to his ingenuity and unwavering commitment to making a positive impact on patient outcomes. We eagerly anticipate the future contributions of this visionary inventor in revolutionizing cancer care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…